Overall rank by patents
#24,917
Across all tracked assignees
USPTO PatentsView assignee record - 11 granted patents across 7 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G01R (MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES).
The verdict
OMNI holds 11 US patents across 7 technology areas, rank #24,917 of 50,000 tracked assignees.
OMNI LPS. Co., Ltd. has been granted 11 US utility patents between 2015 and 2025, placing OMNI LPS. Co., Ltd. at rank #24,917 across all assignees tracked by PlainPatent. This portfolio spans 7 distinct Cooperative Patent Classification (CPC) subclasses, averaging 2.7 claims per patent with primary concentration in G01R (MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES). As a Foreign Corporation, OMNI LPS. Co., Ltd. is one of the more focused assignees in the PatentsView dataset. By volume, OMNI sits between Oertli-instrumente Ag (11 patents, rank #24,913) and Orbis Wheels, Inc. (11 patents, rank #24,921) - the closest US assignees by grant volume. The composite Innovation Score of 21.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 5 grants, compared with 6 in the 2015–2019 window, a -17% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. OMNI LPS. Co., Ltd.'s 2.7 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 7 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark OMNI LPS. Co., Ltd. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
OERTLI-INSTRUMENTE AG
11 patents
OFI Testing Equipment, Inc.
11 patents
OKAZAKI MANUFACTURING COMPANY
11 patents
OMNI CUBED, Inc.
11 patents
ONKOS SURGICAL, INC.
11 patents
OPTOMAK, INC.
11 patents
ORASURE TECHNOLOGIES, INC.
11 patents
ORBIS WHEELS, INC.
11 patents
OMNI LPS. CO., LTD.
11 patents
What this shows OMNI holds 11 patents at rank #24,917, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
OMNI's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
22 Top 91% higher than 9% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 18.2% |
| 2017 | 3 | 27.3% |
| 2018 | 1 | 9.1% |
| 2020 | 2 | 18.2% |
| 2021 | 1 | 9.1% |
| 2023 | 1 | 9.1% |
| 2025 | 1 | 9.1% |
Top 7 of 7 technology areas
Overall rank by patents
#24,917
Across all tracked assignees
21.8 out of 100
How to use this portfolio
OMNI's 11 grants land it in the top 91% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.